- Report
- April 2026
- 266 Pages
United States
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 162 Pages
Canada
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 188 Pages
China
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 214 Pages
Germany
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 240 Pages
India
From €4400EUR$4,850USD£3,792GBP
- Report
- June 2025
- 150 Pages
Global
From €4400EUR$4,850USD£3,792GBP
- Report
- May 2025
- 150 Pages
Global
From €4400EUR$4,850USD£3,792GBP
- Report
- July 2026
- 50 Pages
Global
From €2404EUR$2,650USD£2,072GBP
Acefylline is a respiratory drug used to treat bronchial asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It is a bronchodilator, meaning it helps to open up the airways and make breathing easier. Acefylline is available in both oral and injectable forms. It is often used in combination with other drugs to treat more severe cases of respiratory conditions.
Acefylline is a widely used drug in the respiratory market, with many companies offering it as part of their product portfolio. It is available in both generic and branded forms, with the latter often being more expensive. Companies that produce acefylline include AstraZeneca, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more